HOUSE-BILL 4273: H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments
AI-Powered Summary
HOUSE-BILL 4273 aims to amend the Federal Food, Drug, and Cosmetic Act to streamline the user fee program for over-the-counter (OTC) monograph drugs, thereby enhancing consumer access to safe and effective medications without a prescription. The legislation addresses major themes such as healthcare access, regulatory efficiency, and market competition. Key provisions include the establishment of user fees for OTC drugs, requirements for the FDA to publish fee amounts and adjustments for transparency, and sunset provisions for periodic review and reauthorization of the fee program. Implementation will require the FDA to adjust its regulatory processes to accommodate the new fee structure, with a timeline for reviews and potential adjustments outlined in the bill. Potential impacts include improved access to OTC medications, concerns about the impact of fees on smaller manufacturers and competition, and implications for public trust in the FDA's regulatory practices, all of which could affect consumer choice and health outcomes.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill's implementation of user fees for OTC medications could create barriers to access, particularly for economically disadvantaged groups, raising serious equal protection concerns under the 14th Amendment. The potential for increased costs may limit access to essential healthcare products, which is a fundamental aspect of individual rights.
Key Individual Rights Affected
- Right to Health
- Equal Protection under the Law
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- Commerce Clause
Potential Constitutional Challenges
The bill may face challenges based on its disproportionate impact on low-income individuals and marginalized communities, potentially violating the Equal Protection Clause. Additionally, there may be arguments regarding the extent of federal regulation over health products and its implications for state rights.
Summary
HOUSE-BILL 4273 aims to enhance the safety and efficacy of OTC drugs through a user fee program, but it risks infringing upon the equal protection rights of individuals, particularly those from low-income backgrounds. The financial burden imposed by user fees could limit access to essential medications, raising significant constitutional concerns regarding equity in healthcare access.
Constitutional Analysis
This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 4273 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
July 2, 2025
Bill Introduced
Current
Reported by Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat